Inventor · disambiguated record
Heinz Gisslinger
Also filed as: GISSLINGER HEINZ
3 granted patents·2 pending applications·3 citations·filing 2014–2022
60Inventor score
Files withCEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH4CeMM—FORSCHUNGSZENTRUM FÜR MOLEKULARE MEDIZIN GmbH1
Top patents by PatentIndex Score
5 records- 0171US2022251666A1Mutant calreticulin for the diagnosis of myeloid malignanciesCEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH·Filed 2022·Application pending·0 cites
- 0267US9371570B2Mutant calreticulin for the diagnosis of myeloid malignanciesCeMM—FORSCHUNGSZENTRUM FÜR MOLEKULARE MEDIZIN GmbH·Filed 2014·Granted Jun 21, 2016·2 cites·30 claims
- 0366US11274350B2Mutant calreticulin for the diagnosis of myeloid malignanciesCEMM—FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH·Filed 2019·Granted Mar 15, 2022·0 cites·22 claims
- 0466US10344335B2Mutant calreticulin for the diagnosis of myeloid malignanciesCEMM—FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH·Filed 2014·Granted Jul 9, 2019·1 cites·22 claims
- 0553US2018251852A1Mutant calreticulin for the diagnosis of myeloid malignanciesCEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Heinz Gisslinger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →